CEO & Co-Founder, SoftComply
Marion Lepmets
While much attention has been given to AI-enabled medical devices, this session explores something equally important: How AI is embedded within the tools developers use to build those devices.
AI tooling is changing how medical device software is developed. But when these tools are used in regulated environments, safety, validation, and compliance become critical, and a new set of related (and interesting) challenges arises.
Orthogonal and SoftComply co-hosted a focused conversation about using AI tools responsibly in the development of SaMD and other medical device software.
Our experts explained how FDA and MDR guidance apply to AI-powered development tools, what risk and validation challenges they introduce, and how teams can adopt them safely without slowing innovation.
CEO & Co-Founder, SoftComply
Marion Lepmets
Co-Founder & Chief Regulatory Officer, SoftComply
Matteo Gubellini
Founder & CEO, Orthogonal
Bernhard Kappe
Chief Solutions Officer, Orthogonal
Randy Horton
Related Posts
Talk
SaMD, Digital Ecosystems and the New Rules for Cybersecurity
Talk
Medical Device Manufacturers as Providers: A New and Emerging MedTech Model
Talk
Leveraging Automation to Deliver High-Quality MedTech Software
Talk
The Playbook for Running a Multi-Partner Engineering Organization